Expanding Market Presence The recent acquisition of GlobalCare by Covance significantly broadens their patient-centric decentralized clinical trial offerings into global markets, providing an opportunity to target pharmaceutical companies seeking to enhance trial accessibility and patient engagement worldwide.

Focus on Innovation GlobalCare’s expertise in patient-centric DCTs combined with Covance’s recognition as a leading CRO positions the company as a pioneer in innovative trial designs, making it attractive for clients prioritizing cutting-edge, flexible clinical trial solutions.

Strong Industry Recognition Multiple awards and industry accolades gained by Covance around quality and innovation demonstrate credibility and stability, appealing to potential clients looking for reliable CRO partners with proven excellence.

Strategic Expansion Investments Recent investments into preclinical oncology facilities and advanced assets indicate a focus on expanding capabilities in high-growth therapeutic areas like oncology and cell/gene therapy, providing opportunities to engage biotech and pharma companies targeting these fields.

Financial and Operational Scale Although smaller in revenue compared to global giants, GlobalCare’s unit offers specialized, patient-centric trial solutions within a competitive landscape, ideal for engaging mid-sized pharma firms seeking innovative and flexible trial partnerships.